Showing results (201-210 of 412) with videos related to
Sort By:
Pageof 42
Annals of Internal Medicine|March 25, 2024
Deep Learning to Estimate Cardiovascular Risk From Chest Radiographs : A Risk Prediction StudyJakob Weiss, Vineet K Raghu, Kaavya Paruchuri, et al.European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|February 17, 2018
Raw material variability of an active pharmaceutical ingredient and its relevance for processability in secondary continuous pharmaceutical manufacturingF Stauffer, V Vanhoorne, G Pilcer, et al.Plos One|November 3, 2018
Peritumoral radiomics features predict distant metastasis in locally advanced NSCLCTai H Dou, Thibaud P Coroller, Joost J M van Griethuysen, et al.Expert Opinion on Drug Delivery|February 18, 2021
Layer-by-Layer technique as a versatile tool for gene delivery applicationsDmitrii S Linnik, Yana V Tarakanchikova, Mikhail V Zyuzin, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 24, 2019
Deep Learning Predicts Lung Cancer Treatment Response from Serial Medical ImagingYiwen Xu, Ahmed Hosny, Roman Zeleznik, et al.Archives of Toxicology|March 21, 2023
Evaluation of functional candidate biomarkers of non-genotoxic hepatocarcinogenicity in human liver spheroid co-culturesBruna Dos Santos Rodrigues, Kaat Leroy, Milos Mihajlovic, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 2, 2016
Radiomic-Based Pathological Response Prediction from Primary Tumors and Lymph Nodes in NSCLCThibaud P Coroller, Vishesh Agrawal, Elizabeth Huynh, et al.Frontiers in Oncology|April 12, 2016
Relationship between the Temporal Changes in Positron-Emission-Tomography-Imaging-Based Textural Features and Pathologic Response and Survival in Esophageal Cancer PatientsStephen S F Yip, Thibaud P Coroller, Nina N Sanford, et al.Cancer Immunology, Immunotherapy : CII|April 22, 2016
Disease progression in recurrent glioblastoma patients treated with the VEGFR inhibitor axitinib is associated with increased regulatory T cell numbers and T cell exhaustionStephanie Du Four, Sarah K Maenhout, Daphné Benteyn, et al.International Journal of Cancer|February 22, 2018
Immune checkpoint blockade combined with IL-6 and TGF-β inhibition improves the therapeutic outcome of mRNA-based immunotherapyLukasz Bialkowski, Kevin Van der Jeught, Sanne Bevers, et al.Pageof 42